Glucocorticoids
The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
The most effective anti-inflammatory drugs used to treat patients with airways disease are topical glucocorticosteroids (GCs). These act on virtually all cells within the airway to suppress airway inflammation or prevent the recruitment of inflammatory cells into the airway. They also have profound effects on airway structural cells to reverse the effects of disease on their function. Glucorticosteroids act via specific receptors-the glucocorticosteroid receptor (GR)-which are a member of the nuclear receptor family. As such, many of the important actions of GCs are to modulate gene transcription through a number of distinct and complementary mechanisms. Targets genes include most inflammatory mediators such as chemokines, cytokines, growth factors and their receptors. GCs delivered by the inhaled route are very effective for most patients and have few systemic side effects. However, in some patients, even high doses of topical or even systemic GCs fail to control their disease. A number of mechanisms relating to inflammation have been reported to be responsible for the failure of these patients to respond correctly to GCs and these provide insight into GC actions within the airways. In these patients, the side-effect profile of GCs prevent continued use of high doses and new drugs are needed for these patients. Targeting the defective pathways associated with GC function in these patients may also reactivate GC responsiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic glucocorticoid (GC) treatment represents a widely-prescribed therapy for several diseases in consideration of both anti-inflammatory and immunosuppressive activity”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [5]
In the citing paper
“Furthermore, GR-mediated feedback inhibition on the pituitary only occurs at chronic GC levels that incur adverse peripheral effects [5].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [5]
Citations
Cites
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803
Research works printed but not linked: 11
- Adcock IM, Caramori G, Chung KF (2008b) New targets for drug development in asthma. Lancet 372(9643):1073–1087 · DOI · Paper page
- Brompton Hospital/Medical Research Council Collaborative Trial (1974) Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 2(7876):303–307
- Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, Jia G, Ohri CM, Doran E, Vannella KM, Butler CA, Hargadon B, Sciurba JC, Gieseck RL, Thompson RW, White S, Abbas AR, Jackman J, Wu LC, Egen JG, Heaney LG, Ramalingam TR, Arron JR, Wynn TA, Bradding P (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7(301):301
- Clark TJ (1982) Safety of inhaled corticosteroids. Eur J Respir Dis Suppl 122:235–242
- Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. NHLBI/WHO Workshop report 2002. NHI Publication 02-3659. http://www.ginasthma.com. Accessed 11 May 2015
- Hochhaus G, Druzgala P, Hochhaus R, Huang MJ, Bodor N (1991) Glucocorticoid activity and structure activity relationships in a series of some novel 17 alpha-ether-substituted steroids: influence of 17 alpha-substituents. Drug Des Discov 8(2):117–125
- Hua G, Ganti KP, Chambon P (2016a) Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex. Proc Natl Acad Sci U S A 113(5):E635–E643
- Hua G, Paulen L, Chambon P (2016b) GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc Natl Acad Sci U S A 113(5):E626–E634
- Kupczyk M, Wenzel S (2012) U.S. and. European severe asthma cohorts: what can they teach us about severe asthma? J Intern Med 272(2):121–132
- Nannini LJ, Poole P, Milan SJ, Holmes R, Normansell R (2013) Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 11:CD003794
- Yang IA, Clarke MS, Sim EH, Fong KM (2012) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 7:CD002991
Cited by
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
Deng, Y., Xia, X., Zhao, Y., Zhao, Z., Martinez, C., Yin, W., Yao, J., Hang, Q., Wu, W., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27349-7 · Cited by 157
Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review
Yan, Y., Fu, J., Kowalchuk, R. O., Wright, C. M., Zhang, R., Li, X., & Xu, Y. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-108 · Cited by 135
Uveitis Therapy: The Corticosteroid Options
Valdes, L., & Sobrin, L. (2020) · Drugs · doi:10.1007/s40265-020-01314-y · Cited by 106
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
Aldea, M. D., Orillard, É., Mansi, L., Marabelle, A., Scotté, F., Lambotte, O., & Michot, J. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.032 · Cited by 102
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
Xiang, Z., Liu, J., Shi, D., Chen, W., Li, J., Yan, R., Bi, Y., Hu, W., Zhu, Z., Yu, Y., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47652 · Cited by 93
Ruan, Y., Yuan, P., Li, P.-Y., Chen, Y., Fu, Y., Gao, L., Wei, Y., Zheng, Y., Li, S.-F., Feng, W.-S., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116503 · Cited by 89
Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma
Sahnoon, L., Bajbouj, K., Mahboub, B., Hamoudi, R., & Hamid, Q. A. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09045-2 · Cited by 103
Anderson, K. M., & Gayer, C. P. (2021) · Cells · doi:10.3390/cells10113206 · Cited by 91
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 79
Pofi, R., Feliciano, C., Sbardella, E., Argese, N., Woods, C. P., Grossman, A. B., Jafar-Mohammadi, B., Gleeson, H., Lenzi, A., Isidori, A. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00529 · Cited by 67
Corticosteroid resistance in asthma: Cellular and molecular mechanisms
Caramori, G., Nucera, F., Mumby, S. E., Bello, F. L., & Adcock, I. M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100969 · Cited by 73
Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
Yang, R., & Yu, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58695 · Cited by 69
Pharmacotherapy for Keloids and Hypertrophic Scars
Murakami, T., & Shigeki, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094674 · Cited by 82
Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Yang, M., Ma, F., & Guan, M. (2021) · Metabolites · doi:10.3390/metabo11050320 · Cited by 68
Garza, G. R. C., Elizondo‐Luévano, J. H., Bazaldúa-Rodríguez, A. F., Chávez-Montes, A., Pérez-Hernández, R. A., Delgado, A. J. M., Villarreal, S. M. L., Rodríguez‐Rodríguez, J., Sánchez‐Casas, R., Castillo-Velázquez, U., et al. (2021) · Plants · doi:10.3390/plants10091908 · Cited by 70
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 59
New drugs under development for COPD
Uwagboe, I., Adcock, I. M., Bello, F. L., Caramori, G., & Mumby, S. E. (2022) · Minerva Medica · doi:10.23736/s0026-4806.22.08024-7 · Cited by 68
Advances with glucocorticoids in the treatment of asthma: state of the art
Ora, J., Calzetta, L., Matera, M. G., Cazzola, M., & Rogliani, P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1807514 · Cited by 56
Chen, X., Li, Y., Qin, L., He, R., & Hu, C. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1778720 · Cited by 53
How can we minimise the use of regular oral corticosteroids in asthma?
BOURDIN, A. A., Adcock, I. M., Berger, P., Bonniaud, P., Chanson, P., Chenivesse, C., Jacques de, B. L. I. C., Deschildre, A., Devillier, P., Devouassoux, G., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0085-2019 · Cited by 53
Martínez‐García, M. Á., Oscullo, G., García‐Ortega, A., Matera, M. G., Rogliani, P., & Cazzola, M. (2022) · Drugs · doi:10.1007/s40265-022-01785-1 · Cited by 42
Eshraghi, A. A., Jung, H. D., & Mittal, R. (2019) · The Anatomical Record · doi:10.1002/ar.24107 · Cited by 44
Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
Михайловна, Ж. Е., Lylova, E. S., Grigoreva, D. D., Игоревич, К. К., Osipova, A. V., Kulikov, E. P., Александрович, М. С., Belitsky, G. A., Budunova, I. V., Геннадиевна, Я. М., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179686 · Cited by 37
The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When
Salvetat, M. L., Pellegrini, F., Spadea, L., Salati, C., Musa, M., Gagliano, C., & Zeppieri, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051327 · Cited by 47
“Both endogenous and synthetic steroids bind specific glucocorticoid receptors and regulate the expression of approximately 10–20% of the human genome in almost all cell types, resulting in glucose metabolism, growth, development, survival, and inflammation control [67,68].”
BackgroundInfluentialAirway Smooth Muscle–Specific Transcriptomic Signatures of Glucocorticoid Exposure
Kan, M., Koziol‐White, C. J., Shumyatcher, M., Johnson, M. T., Jester, W. F., Panettieri, R. A., & Himes, B. E. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0385oc · Cited by 37
Glucocorticoid circadian rhythms in immune function
Olejniczak, I., Oster, H., & Ray, D. W. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00889-2 · Cited by 45
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment
Matera, M. G., Rinaldi, B., Calzetta, L., Rogliani, P., & Cazzola, M. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.101828 · Cited by 40
Nanomedicine Strategies for Anti‐Inflammatory Treatment of Noninfectious Arthritis
Chen, L., Wang, Y., Sun, L., Yan, J., & Mao, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001732 · Cited by 44
PMMA Safety for Facial Filling: Review of Rates of Granuloma Occurrence and Treatment Methods
Paulucci, B. (2019) · Aesthetic Plastic Surgery · doi:10.1007/s00266-019-01522-2 · Cited by 43
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 35
Wang, T., Zhou, Q., & Shang, Y. (2020) · Journal of Innate Immunity · doi:10.1159/000509714 · Cited by 33
Raksasuk, S., & Ungprasert, P. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02346-4 · Cited by 29
Cao, Y., Jiang, C., Wang, X., Wang, H., Yan, Z., & Yuan, H. (2021) · Bone · doi:10.1016/j.bone.2021.115844 · Cited by 26
Genetic Susceptibility to Drug Teratogenicity: A Systematic Literature Review
Gomes, J. D. A., Olstad, E. W., Kowalski, T. W., Gervin, K., Vianna, F. S. L., Schüler‐Faccini, L., & Nordeng, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.645555 · Cited by 31
Pharmacological Management of Acute Endodontic Pain
khan, A. W. A., & Diogenes, A. R. (2021) · Drugs · doi:10.1007/s40265-021-01564-4 · Cited by 33
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
del Pozo, V., Bobolea, I. D., Rial, M. J., Espígol‐Frigolé, G., Solans, R., Hernández‐Rivas, J. M., Mora, E., Lessmann, A. C., Alonso, J. L. I., Sosa, M. S. D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1310211 · Cited by 31
“In both cases, because SGC are often used in high doses and/or over prolonged periods, patients are at increased risk of well-known SGC-related adverse effects (AEs), such as serious infection (16), and corticoresistance (17 – 19).”
BackgroundPofi, R., Gunatilake, S. S. C., Macgregor, V., Shine, B. S. F., Joseph, R. N., Grossman, A. B., Isidori, A. M., Cudlip, S., Jafar‐Mohammadi, B., Tomlinson, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00406 · Cited by 26
Hou, J., Wang, J., Meng, J., Zhang, X., Niu, Y.-J., Gao, J., Bai, Y.-E., & Zhou, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/2073296 · Cited by 27
Quantitative MALDI-MS assay of steroid hormones in plasma based on hydroxylamine derivatization
Song, Z., Gao, H., Xie, W., Sun, Q. Y., Liang, K., & Li, Y. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114089 · Cited by 23
Li, K., Yu, X., Maskey, A., Musa, I., Wang, Z.-Z., Garcia, V. G., Guo, A. M., Yang, N., Srivastava, K. D., Dunkin, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1042756 · Cited by 20
Adrenal insufficiency associated with long-term use of inhaled steroid in asthma
Choi, I. S., Sim, D. W., Kim, S., & Wui, J.-W. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.10.002 · Cited by 18
Kaboli, S. F., Mehrnejad, F., & Nematollahzadeh, A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102588 · Cited by 18
Developmental Abnormalities of Teeth in Children With Nephrotic Syndrome
Piekoszewska‐Ziętek, P., Olczak‐Kowalczyk, D., Pańczyk-Tomaszewska, M., & Gozdowskı, D. (2022) · International Dental Journal · doi:10.1016/j.identj.2021.11.014 · Cited by 23
Shu, Y., Xue, S., Wang, T., Gao, R., Zeng, H., Wang, Q., & Jia, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1086214 · Cited by 20
Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship
BOURDIN, A. A., Suehs, C., & Charriot, J. (2020) · European Respiratory Journal · doi:10.1183/13993003.02193-2019 · Cited by 16
Novel pharmacological therapies for the treatment of bronchial asthma
AMISON, R. T., & Page, C. P. (2021) · Minerva Medica · doi:10.23736/s0026-4806.21.07559-5 · Cited by 15
Ouyang, S., Lu, P., Li, J., Jin, H., Wu, W., Luo, R., Wang, B., Huang, X., Lian, X., & Huang, G. (2024) · Respiratory Research · doi:10.1186/s12931-024-02947-3 · Cited by 18
Takada, S., Matsubara, T., Fujii, H., Sato-Matsubara, M., Daikoku, A., Odagiri, N., Amano‐Teranishi, Y., Kawada, N., & Ikeda, K. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00509-x · Cited by 15
Miao, K., & Zhang, L. (2023) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2023.08.002 · Cited by 15
“75 Glucocorticoids exerts anti-inflammatory effects through cytosolic glucocorticoid receptor 𝛼 (cGCR 𝛼 ), which promotes the transcription and translation of anti-inflammatory proteins.”
Song, W., Wang, Y., Tian, F., Ge, L., Shang, X., Zeng, Q., Ning, F., Fan, J., Wang, J., & Ma, X. (2021) · Disease Markers · doi:10.1155/2021/8879401 · Cited by 13
The Potential Relationship Between Low Back Pain and Depression: A Comprehensive Review
Cao, L., Deng, B., Wang, X., Fang, T., Umoh, K., Liu, L., Qian, J., & Liu, F. (2025) · Brain and Behavior · doi:10.1002/brb3.71026 · Cited by 14
Rosado, M. R. S., Marzan-Rivera, N., Watowich, M. M., Valle, A. D. N.-D., Pantoja, P., Pavez-Fox, M. A., Siracusa, E. R., Cooper, E. B., Valle, J. E. N.-D., Phillips, D., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00962-8 · Cited by 15
Lesovaya, E. A., Savinkova, A. V., Morozova, O. V., Lylova, E. S., Михайловна, Ж. Е., Kulikov, E. P., Игоревич, К. К., Kłopot, A., Baida, G. E., Геннадиевна, Я. М., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1111 · Cited by 11
Tao, F., Zhou, Y., Wang, M., Wang, C., Zhu, W.-T., Han, Z., Sun, N., & Wang, D. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.2.95 · Cited by 13
Kong, Q., Mo, S., Wang, W., Tang, Z., Wei, Y., Du, Y., Liu, B., Kong, L., Lv, Y., & Dong, J. (2020) · Trials · doi:10.1186/s13063-020-04669-5 · Cited by 10
Luo, X., Yu, S., Zeng, Z., Zhou, X., Liu, Y., Wang, G., Hu, J., & Chang, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952098 · Cited by 12
Ryan, K. M., Boyle, N. T., Harkin, A., & Connor, T. J. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577082 · Cited by 12
Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
López-Méndez, I., Maldonado-Rojas, A. D. C., Uribe, M., & Juárez-Hernández, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1213372 · Cited by 10
Pelizzo, G., Calcaterra, V., Baldassarre, P., Marinaro, M., Taranto, S., Ceresola, M., Capelo, G., Gazzola, C., & Zuccotti, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1425149 · Cited by 13
Glucocorticoid Therapy in COVID-19
Amati, F., Tonutti, A., Huston, J. C., & Cruz, C. S. D. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1759778 · Cited by 10
Zhang, Y., Li, S., Yan, C., Chen, J., & Shan, F. (2021) · Cancer Management and Research · doi:10.2147/cmar.s333414 · Cited by 8
The role of hormones in ILC2 ‐driven allergic airway inflammation
Dai, Z., Gong, Z., Wang, C., Long, W., Liu, D., Zhang, H., & Lei, A. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13357 · Cited by 8
“30,31 GCs have been widely used to counteract the cytokine storm in serious asthmatic conditions and chronic obstructive pulmonary disease.”
MethodMa, Z., Xie, Y., Ma, Z., Li, Y., Long, Y., Tang, X., & Liu, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119245 · Cited by 6
Post COVID-19 complications, adjunct therapy explored, and steroidal after effects
Sonkar, C., Hase, V., Banerjee, D., Kumar, A., Kumar, R., & Jha, H. C. (2022) · Canadian Journal of Chemistry · doi:10.1139/cjc-2021-0247 · Cited by 7
Li, X., Zeng, Z., Fan, X., Wang, W., Luo, X., Yang, J., & Chang, Y. (2023) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s436747 · Cited by 6
Li, S., Zhao, Q., Zhen, Y., Li, L., Mi, Y., Li, T., Liu, K., & Liu, C. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s334132 · Cited by 5
Budesonide in the first line treatment of patients with autoimmune hepatitis
Olivas, I., Cobreros, M., Londoño, M., & Díaz‐González, Á. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.11.012 · Cited by 6
Effect of combined glucocorticoid therapy on bronchial asthma dynamics
Batrakova, E., Kartashova, O., Babaskina, L. I., & Pashanova, O. V. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i1.481 · Cited by 5
Wang, D., Wang, W., Zhang, Q., Liu, C., Li, X., Zuo, K., Xie, Y., & Zhang, X. (2024) · Current Drug Delivery · doi:10.2174/0115672018315617240826133041 · Cited by 6
Pérez, F. J., Iturra, P. A., Ponce, C. A., Magne, F., García-Angulo, V. A., & Vargas, S. L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01522 · Cited by 5
da Silva, D. A. C., Almeida, F. D. L. D. S., Ota, T. M. N., Guimarães, D. M., & Fernandes, K. P. S. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.07.006 · Cited by 5
Excess weight increases the risk of sarcopenia in patients with multiple sclerosis
de Carvalho, B. M., Silva, R. S. C., de Lima, V. V. M., Almondes, K. G. D. S., Rodrigues, F. N. S., D’Almeida, J. A. C., & de Melo, M. L. P. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105049 · Cited by 9
Yeon, S.-M., Choi, A., Hong, M. S., & Jung, Y. W. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01159-4 · Cited by 5
Chen, J., Xu, N., Sun, H.-L., & Chen, G. (2021) · Journal of Ophthalmology · doi:10.1155/2021/9799274 · Cited by 4
“Genomic actions ultimately cause increased synthesis of anti-inflammatory proteins and decreased synthesis of proinflammatory proteins [20, 21].”
Михайловна, Ж. Е., Savina, E. D., Yurchenko, E. A., & Lesovaya, E. A. (2025) · Marine Drugs · doi:10.3390/md23100399 · Cited by 7
Khan, M. A., Islam, S. B., Rakib, M. U., Alam, D., Hossen, M. M., Tania, M., & Asad, A. (2020) · Coronaviruses · doi:10.2174/2666796701999201204122819 · Cited by 4
Wang, J., Xie, Y., Liu, L., Rong, S., Cai, H., Zeng, H., Zhou, L., Deng, K., Dai, M., Xu, C., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011479 · Cited by 7
“23 On binding glucocorticoid, the glucocorticoid receptor (GR), encoded by NR3C1, translocates from its inactive cytoplasmic location to the nucleus.”
Zheng, X., Li, C., & Gao, X. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5081 · Cited by 4
Jalalinajafabadi, F., Bailey, R., Lyons, J., Akbari, A., Dhafari, T. B., Azadbakht, N., Rafferty, J., Watkins, A. J., Martin, G. P., Bowes, J., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079169 · Cited by 6
Deacetylation by SIRT6 increases the stability of GILZ to suppress NSCLC cell migration and invasion
Chen, S., Yang, H., Hu, Z., Jin, J., Xiong, X., Zhang, Z., & Xie, C. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111414 · Cited by 4
Lv, Y., Chen, Y., Hu, L., Ding, H., Liu, M., Li, H., Hou, Y., & Xing, Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15833 · Cited by 3
Rosado, M. R. S., Marzan-Rivera, N., Watowich, M. M., Valle, A. D. N.-D., Pantoja, P., Pavez-Fox, M. A., Siracusa, E. R., Cooper, E. B., Valle, J. E. N.-D., Phillips, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.06.471383 · Cited by 3
Domínguez-González, D., Romero-Llopis, B., Roldán-Lázaro, M., Baquero, L., Noverques, R., Pallardó, F. V., Navarro, J. A., & González‐Cabo, P. (2024) · Redox Experimental Medicine · doi:10.1530/rem-24-0004 · Cited by 5
Immunomodulatory and Anti-Inflammatory Properties of Glucocorticoids
Ayroldi, E., Migliorati, G., & Riccardi, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00052-9 · Cited by 2
Wiącek, M. P., Brzosko, M., Lubiński, W., & Modrzejewska, M. (2021) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.01.11 · Cited by 2
D’Amico, E., Cinquini, C., Petrini, M., Barone, A. A., Iezzi, G., D’Ercole, S., Filippis, B. D., & Pierfelice, T. V. (2024) · Metabolites · doi:10.3390/metabo14070350 · Cited by 2
“…increased risk of infection, delayed wound healing, bone loss, and oral thrush [6,7]. enzymatic and chemical stability, and good These glucocorticoids-induced side effects could be linked to their potential to increase the production of ROS within oral tissues [8,9]. wound-healing properties [30].”
BackgroundGuo, Z., Liu, J., Fang, Y.-N., Guo, X.-M., Ma, C.-L., & Wang, J. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117313 · Cited by 2
Current status of intranasal glucocorticosteroids in the management of allergic rhinitis
Okano, M. (2008) · Clinical & Experimental Allergy Reviews · doi:10.1111/j.1472-9733.2008.00138.x · Cited by 2
Wang, J., Li, X., Shen, B., Wang, S., He, J., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900701 · Cited by 3
The use of local glucocorticosteroids in veterinary practice - An overview
Pul-Luzan, V., Олійник, С. В., Tatyana, Y., Olga, R., & Oksana, D. (2021) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/ihd43aumkw · Cited by 1
Understanding Glucocorticoid-induced Osteoporosis: Causes, Effects and Management
Ghamari, M., Ebrahimzadeh, F., & Hashemzadeh, K. (2025) · Indian Journal of Rheumatology · doi:10.1177/09733698251345210 · Cited by 1
Ferreira, A. M., Silva, M. I., Torres-Costa, S., Oliveira-Ferreira, C., Pedrosa, A. C., Figueira, L., & Araújo, J. R. (2025) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-025-00558-7 · Cited by 2
Nie, Q., Liu, J., Cui, Y., Li, F., Bello, M. G., Wang, J., Zheng, S., Shao, S., Wu, L., Wang, C., et al. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126627 · Cited by 1
Natural bioactive as modulators of airway inflammation and remodeling: mechanistic insights
Singh, P. (2026) · 3 Biotech · doi:10.1007/s13205-026-04822-y · Cited by 2
Computational Docking and in Silico Toxicity Prediction of Polydatin as a Potential TNF-α Modulator
Ferrari, I. V., Fuggetta, M. P., & Ravagnan, G. (2026) · European journal of applied sciences · doi:10.14738/ejas.1403.1264 · Cited by 1
Targeting Molecular and Cellular Mechanisms in Steroid-Resistant Asthma
Dutta, J., Singh, S., Ray, A., & Mabalirajan, U. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_4 · Cited by 1
Zhao, Q., He, C., Liu, B., Yang, X., Zhao, Y., & Yuan, D. (2023) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2023.3548 · Cited by 1
Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects
Hodel, K. V. S., Fonsêca, A. F., Barbosa, I. A. B., Medina, C., Alves, B. K. A. M. D. F., Maciel, C. A. D. O., Nascimento, D., Oliveira-Junior, G. S., Pedreira, L. A., de Souza, M., et al. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010264503231108070917 · Cited by 2
Bykov, Y. V., Обедин, А. Н., Zinchenko, О. V., & Yatsuk, I. V. (2025) · EMERGENCY MEDICAL CARE · doi:10.24884/2072-6716-2024-25-3-92-97 · Cited by 1
Metadata
- Authors
- Adcock, I. M., & Mumby, S.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Adcock, Ian M.
- Venue
- Handbook of experimental pharmacology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 237
- Pages
- 171-196
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W4211105534
- Cited by
- 131
- References
- 137
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 19 · 2023: 15 · 2022: 14 · 2021: 30 · 2020: 15 · 2019: 13 · 2018: 1 · 2017: 1 · 2016: 1
- FWCI
- 21.63
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation (PG/14/27/30679)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- glucocorticoids, topical glucocorticosteroids, airway inflammation, glucocorticoid receptor, nuclear receptors, gene transcription, chemokines, cytokines, inhaled corticosteroids, glucocorticoid resistance, glucocorticoid adverse effects, anti-inflammatory agents
- MeSH terms
- Animals, Asthma, Glucocorticoids, Humans, Receptors, Glucocorticoid, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.